Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (Q3)Nov 30, 2025 | (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 328.29%11.72K | 823.43%8.39K | 729.17%2.99K | 997.43%5.55K | 205.93%1.55K | 2.74K | 909 | 360 | -89.63%506 | 506 |
| Operating revenue | 328.29%11.72K | 823.43%8.39K | 729.17%2.99K | 997.43%5.55K | 205.93%1.55K | --2.74K | --909 | --360 | -89.63%506 | --506 |
| Cost of revenue | 190.20%145.51K | -0.03%50.13K | -0.03%50.13K | 0.04%50.14K | 0.04%50.14K | 0.04%50.14K | ||||
| Gross profit | -182.23%-133.79K | 15.23%-41.73K | 5.30%-47.14K | 5.42%-47.4K | 1.77%-49.23K | 0.68%-49.78K | ||||
| Operating expense | 402.01%1.9M | 762.35%2.92M | 26.92%448.76K | -0.03%2.13M | 54.42%1.06M | -12.35%379.22K | -32.23%338.19K | -31.24%353.58K | -39.34%2.13M | 108.83%687.58K |
| Selling and administrative expenses | 541.85%1.79M | 1,108.78%2.8M | 46.76%322.39K | 80.61%1.62M | 115.90%894.05K | 140.55%279.11K | 32.33%231.83K | 13.09%219.67K | -58.11%899.55K | -35.83%414.1K |
| -Selling and marketing expense | 99.01%64.96K | 8.97%53.04K | 3.13%53K | 43.73%237.89K | 307.63%105.18K | 16.87%32.64K | -10.95%48.67K | -10.02%51.39K | -42.78%165.51K | -66.73%25.8K |
| -General and administrative expense | 600.50%1.73M | 1,401.05%2.75M | 60.08%269.39K | 88.92%1.39M | 103.16%788.88K | 179.76%246.46K | 51.96%183.15K | 22.72%168.28K | -60.50%734.04K | -31.61%388.3K |
| Research and development costs | 71.12%111.92K | 58.84%113.73K | 103.15%126.02K | 59.52%332.03K | 503.96%133K | 11.74%65.4K | 8.92%71.6K | 0.29%62.03K | -33.14%208.14K | -67.98%22.02K |
| Depreciation amortization depletion | -98.98%355 | -98.98%354 | -99.51%355 | -82.84%176.07K | -86.20%34.71K | -86.55%34.71K | -86.53%34.76K | -72.15%71.88K | -3.08%1.03M | 165.34%251.46K |
| -Depreciation and amortization | -98.98%355 | -98.98%354 | -99.51%355 | -82.84%176.07K | -86.20%34.71K | -86.55%34.71K | -86.53%34.76K | -72.15%71.88K | -3.08%1.03M | 165.34%251.46K |
| Operating profit | -377.58%-2.04M | -663.54%-2.96M | -22.94%-495.9K | 0.27%-2.13M | -69.51%-909.8K | 11.63%-426.63K | 29.45%-387.42K | 28.52%-403.36K | 39.27%-2.13M | -410.25%-536.72K |
| Net non-operating interest income (expenses) | -748.63%-947 | -423.40%-1.87K | -121.24%-55 | -61.21%211 | -381.88%-771 | -48.41%146 | 213.59%577 | 9.28%259 | 121.18%544 | 84.41%-160 |
| Non-operating interest income | -65.80%263 | ---- | -27.66%570 | 3.63%3.23K | -27.85%570 | -2.53%769 | 41.49%1.1K | 4.10%788 | 21.37%3.11K | -39.28%790 |
| Non-operating interest expense | ---- | --310 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other finance cost | 94.22%1.21K | 198.66%1.56K | 18.15%625 | 17.37%3.01K | 41.16%1.34K | 23.12%623 | -11.99%521 | 1.73%529 | -49.96%2.57K | -59.17%950 |
| Other net income (expenses) | 69.13%30.17K | 542.00%11.21K | -2,761.96%-44.08K | -440.30%-376.65K | 80.90%-393.61K | -99.04%17.84K | 98.30%-2.54K | -99.65%1.66K | 101.80%110.68K | -15.87%-2.06M |
| Gain on sale of security | 69.13%30.17K | 542.00%11.21K | -2,761.96%-44.08K | 1,870.55%55.91K | 11,166.48%38.95K | 1,355.14%17.84K | -19.12%-2.54K | -99.65%1.66K | -106.04%-3.16K | -109.53%-352 |
| Special income (charges) | ---- | ---- | ---- | -272.55%-432.56K | 77.51%-432.56K | --0 | --0 | ---- | 104.03%250.69K | -7.93%-1.92M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | -85.52%432.56K | -91.62%432.56K | --0 | ---- | ---- | 5.25%2.99M | 472.67%5.16M |
| -Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- | -200.00%-3.16M | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 134.13%77.18K | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---136.85K | ---- |
| Income before tax | -391.45%-2.01M | -657.30%-2.95M | -34.52%-540.04K | -23.84%-2.5M | 49.80%-1.3M | -129.86%-408.64K | 44.25%-389.37K | -327.43%-401.44K | 79.11%-2.02M | -37.82%-2.6M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -391.45%-2.01M | -657.30%-2.95M | -34.52%-540.04K | -23.84%-2.5M | 49.80%-1.3M | -129.86%-408.64K | 44.25%-389.37K | -327.43%-401.44K | 79.11%-2.02M | -37.82%-2.6M |
| Net income continuous operations | -391.45%-2.01M | -657.30%-2.95M | -34.52%-540.04K | -23.84%-2.5M | 49.80%-1.3M | -129.86%-408.64K | 44.25%-389.37K | -327.43%-401.44K | 79.11%-2.02M | -37.82%-2.6M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -391.45%-2.01M | -657.30%-2.95M | -34.52%-540.04K | -23.84%-2.5M | 49.80%-1.3M | -129.86%-408.64K | 44.25%-389.37K | -327.43%-401.44K | 79.11%-2.02M | -37.82%-2.6M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -391.45%-2.01M | -657.30%-2.95M | -34.52%-540.04K | -23.84%-2.5M | 49.80%-1.3M | -129.86%-408.64K | 44.25%-389.37K | -327.43%-401.44K | 79.11%-2.02M | -37.82%-2.6M |
| Diluted earnings per share | -133.33%-0.07 | -266.67%-0.11 | 0.00%-0.03 | 11.11%-0.16 | 69.57%-0.07 | -125.00%-0.03 | 50.00%-0.03 | -200.00%-0.03 | 81.82%-0.18 | -21.05%-0.23 |
| Basic earnings per share | -133.33%-0.07 | -266.67%-0.11 | 0.00%-0.03 | 11.11%-0.16 | 69.57%-0.07 | -125.00%-0.03 | 50.00%-0.03 | -200.00%-0.03 | 81.82%-0.18 | -21.05%-0.23 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.